Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-25-005151
Filing Date
2025-08-07
Accepted
2025-08-07 07:00:20
Documents
2
Period of Report
2025-08-07

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_080725.htm 6-K 4232
2 PRESS RELEASE exh_991.htm EX-99.1 11887
  Complete submission text file 0001171843-25-005151.txt   17162
Mailing Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5
Business Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5 403-607-2621
XORTX Therapeutics Inc. (Filer) CIK: 0001729214 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)